Home/News/Egg Producers Settle US Claims of Price Manipulation
Financial Times2 min read

Egg Producers Settle US Claims of Price Manipulation

Egg Producers Settle US Claims of Price Manipulation

Several major U.S. egg producers have agreed to a settlement in a multi-year legal battle accusing them of manipulating benchmark prices. The lawsuit, filed by federal and state authorities, alleged that these companies engaged in a three-year effort to coordinate bids and artificially inflate egg price quotations. This alleged manipulation is said to have directly impacted the prices consumers paid for eggs across the country.

The settlement aims to resolve claims that the producers, including Cal-Maine Foods Inc., Rose Acre Farms, and others, worked together to control supply and influence the prices reported by the U.S. Department of Agriculture (USDA). These USDA reports serve as key benchmarks for the wholesale egg market. The plaintiffs argued that this coordinated action led to higher prices for both consumers and businesses that purchase eggs.

While the specific financial terms of the settlement were not immediately disclosed, the agreement signifies a significant development in the ongoing scrutiny of agricultural commodity pricing. The investigation and subsequent lawsuit highlighted concerns about market fairness and the potential for collusion among large players in the food industry. The resolution of these claims is expected to bring a degree of closure to the affected parties and potentially deter similar practices in the future.

This legal action underscores the importance of transparent pricing mechanisms in essential food markets. The alleged scheme involved influencing the supply of eggs through various means, such as adjusting flock sizes and production levels, to align with the goal of inflating benchmark prices. The outcome of this settlement will likely be closely watched by other agricultural sectors and consumer advocacy groups concerned with price gouging and anti-competitive behavior.

Original source — read the full reporting at the publisher:

Read on Financial Times

Read next